Literature DB >> 32675576

Medical-Grade Honey for the Treatment of Extravasation-Induced Injuries in Preterm Neonates: A Case Series.

Eleftherios Smaropoulos1, Niels A J Cremers.   

Abstract

INTRODUCTION: Preterm neonates often depend on peripheral intravenous administration of nutrition and medication. Since their skin is not fully developed and very vulnerable, extravasation injury is a risk. Medical-grade honey (MGH) possesses antimicrobial activity and stimulates wound healing; although its use in neonatal patients is limited. CLINICAL
FINDINGS: We present a case series of 7 preterm neonates (28-36 weeks of gestation) with extravasation injuries secondary to peripheral intravenous administration of total parental nutrition and medication. PRIMARY DIAGNOSIS: Extravasation injury following the unintentional leakage of total parenteral nutrition, and medication into the surrounding tissue. Signs of extravasation include local pain, erythema, burning, pruritus, and/or swelling.
INTERVENTIONS: All extravasation injuries were treated with daily cleaning and application of MGH. Some of the cases needed additional surgical intervention or assisted debridement. OUTCOMES: After treatment, all extravasation injury wounds presented with granulation tissue formation progressed to normal epithelialization and closed in 7 to 67 days (median: 32 days). Upon initial application, peripheral edema and inflammation decreased. When present, necrotic tissue was effectively debrided, slough was removed, and no signs of infection were detected, irrespective of initial wound presentations. Cicatrization was minimal, and the full range of motion was preserved in all cases. PRACTICE RECOMMENDATIONS: Continuous and thorough assessment of peripheral intravenous line placement for malposition, leaking, and signs of extravasation is needed for fast discovery and prevention of further damage.
CONCLUSION: Medical-grade honey possesses antimicrobial, anti-inflammatory, and antioxidative activity, enhancing wound healing. Medical-grade honey was safe and effective for treating extravasation-induced injuries, independent of location and severity. We recommend MGH for treating extravasation wounds and consideration for other types of wounds.
Copyright © 2020 by the National Association of Neonatal Nurses.

Entities:  

Mesh:

Year:  2021        PMID: 32675576     DOI: 10.1097/ANC.0000000000000781

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  5 in total

1.  Synergistic Antimicrobial Activity of Supplemented Medical-Grade Honey against Pseudomonas aeruginosa Biofilm Formation and Eradication.

Authors:  Carlos C F Pleeging; Tom Coenye; Dimitris Mossialos; Hilde de Rooster; Daniela Chrysostomou; Frank A D T G Wagener; Niels A J Cremers
Journal:  Antibiotics (Basel)       Date:  2020-12-04

Review 2.  Therapeutic Potential of Bioactive Compounds in Honey for Treating Osteoarthritis.

Authors:  Carlos Martinez-Armenta; María Carmen Camacho-Rea; Gabriela Angélica Martínez-Nava; Rocio Espinosa-Velázquez; Carlos Pineda; Luis Enrique Gomez-Quiroz; Alberto López-Reyes
Journal:  Front Pharmacol       Date:  2021-04-21       Impact factor: 5.810

3.  Antifungal Activity of a Medical-Grade Honey Formulation against Candida auris.

Authors:  Theun de Groot; Tom Janssen; Dirk Faro; Niels A J Cremers; Anuradha Chowdhary; Jacques F Meis
Journal:  J Fungi (Basel)       Date:  2021-01-13

4.  L-Mesitran Foam: Evaluation of a New Wound Care Product.

Authors:  Segametsi Mary-Jane Mthanti; Gloria Pelle; Niels A J Cremers
Journal:  Case Rep Dermatol Med       Date:  2022-04-14

5.  Medical-Grade Honey Outperforms Conventional Treatments for Healing Cold Sores-A Clinical Study.

Authors:  Piyu Parth Naik; Dimitris Mossialos; Bas van Wijk; Petra Novakova; Frank A D T G Wagener; Niels A J Cremers
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.